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 1 
INTERPRETIVE SUMMARY  1 
Comparison of genomic and antimicrobial resistance features of Staphaureux latex test 2 
positive and Staphaurex latex test negative Staphylococcus aureus causing bovine mastitis 3 
Moser 4 
 5 
More than 50% of Staphylococcus (S.) aureus strains causing bovine mastitis are latex test 6 
negative in the Staphaureux latex agglutination test. Our study associated the latex agglutination 7 
phenotype of 78 S. aureus bovine mastitis isolates from 57 Swiss farms with genomic and 8 
antibiotic resistance features. We identified major differences between latex test positive and 9 
latex test negative strains with regard to antibiotic resistance, virulence gene profiles, and the 10 
assigned clonal complexes. The generated data provides new insights into genomic features of 11 
latex test positive and latex test negative strains. It also contributes to the identification of 12 
potential vaccine targets.  13 
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ABSTRACT 38 
The dairy industry suffers from massive economic losses due to staphylococcal mastitis in cattle. 39 
Staphaureux latex agglutination test was reported to lead to negative results in 54% of bovine S. 40 
aureus strains and latex-negative strains were hypothesized to be less virulent than Staphaurex 41 
test positive strains. However, comparative information on virulence and resistance profiles of 42 
these two groups of S. aureus is scarce. Our objective was to associate the latex agglutination 43 
phenotype of S. aureus strains isolated from bovine mastitis milk with data on clonal complexes, 44 
virulence genes, and antibiotic resistance in order to 1) determine the virulence profiles of the 45 
Staphaureux test positive and Staphaurex test negative groups, and 2) provide data needed to 46 
improve treatment of bovine mastitis and to identify potential vaccine targets. A total of 78 S. 47 
aureus strains isolated from 78 different cows at 57 Swiss farms were characterized. Latex 48 
agglutination was tested by Staphaureux kit and resistance profiles were generated by disk 49 
diffusion. DNA microarray was used to assign clonal complexes and to determine virulence and 50 
resistance gene profiles. In the Staphaureux test, 49% of the isolates were latex-positive and 51% 51 
latex-negative. All latex-negative strains were assigned to CC151, whereas latex-positive strains 52 
were assigned to various clonal complexes including CC97 (n = 16), CC8 (n = 10), CC479 (n = 53 
5), CC20 (n = 4), CC7 (n = 1), and CC45 (n = 1). While the latex-negative isolates were 54 
susceptible to all antimicrobial agents tested, 24% of latex-positive isolates were classified 55 
intermediate with regard to cefalexin-kanamycin and 13 % were resistant to both ampicillin and 56 
penicillin. Microarray profiles of latex-negative isolates were highly similar, but differed largely 57 
from those of latex-positive isolates. While the latex-negative group lacked several enterotoxin 58 
genes and the sak, it exhibited significantly higher prevalence rates of genes encoding enterotoxin 59 
C, toxic shock syndrome toxin, and leukocidins (lukM/lukF-P83, lukD). Our findings suggest 60 
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latex-negative isolates to represent a group of closely related strains with specific resistance and 61 
virulence gene patterns.  62 
 63 
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INTRODUCTION 67 
The dairy industry suffers from massive economic losses due to staphylococcal mastitis in cattle 68 
(Wells et al., 1998). Stutz et al. (Stutz et al., 2011) reported that 54% of S. aureus isolates 69 
obtained from cases of bovine mastitis are negative in the Staphaureux latex agglutination test, a 70 
diagnostic instrument widely used to confirm putative S. aureus isolates. These false-negative 71 
results are due to sequence polymorphisms leading to impaired functionality of one or several of 72 
the targeted virulence factors Spa (staphylococcal protein A), ClfA/B (clumping factor A/B), and 73 
FnbA/B (fibronectin binding proteins A/B). Therefore, Staphaurex latex agglutination test 74 
negative (SLAT(-)) strains have been hypothesized to be less virulent than Staphaurex latex 75 
agglutination test positive (SLAT(+)) strains (Stutz et al., 2011). Although the assessment of the 76 
virulence potential of SLAT(-) strains is of crucial importance to the dairy industry, data on the 77 
genomic background and antimicrobial resistance of bovine SLAT(-) isolates is scarce.  78 
Though antibiotic treatment is widely used to fight bovine mastitis, its merits are controversially 79 
discussed. Use of antimicrobial agents is not only economically questionable and favors the 80 
development of antibiotic resistance, but it is also unsuitable to address the issue of intracellular 81 
persistance of the organism (Fluit, 2012; Saini et al., 2012; Steeneveld et al., 2011). Therefore, 82 
increased efforts are now focused on the development of vaccines. Recent studies postulate 83 
extended characterization of the genetic background of bovine mastitis isolates to enable 84 
identification of proteins crucial for colonization and infection that could serve as biomarkers in 85 
the identification of vaccine targets (Fluit, 2012; Klein et al., 2012).  86 
The objective of this study is to link the latex agglutination phenotype of S. aureus strains 87 
isolated from bovine mastitis milk with data on clonal complexes, virulence genes, and antibiotic 88 
resistance in order to 1) determine the virulence profiles of the SLAT(+) and SLAT(-) groups, 89 
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and 2) provide data needed to improve treatment of bovine mastitis and to identify potential 90 
vaccine targets.  91 
 92 
MATERIALS AND METHODS 93 
Bacterial Isolates, DNA Extraction and Species Identification 94 
A total of 78 S. aureus strains was isolated from bovine mastitis milk samples collected 95 
from different cows at 57 Swiss farms between March 2011 and Feb 2012. Putative S. aureus 96 
isolates were identified by streaking samples onto rabbit plasma fibrinogen plates (Oxoid, Basel, 97 
Switzerland), which were subsequently incubated at 37°C and examined for coagulase activity 98 
after 48 h. A single S. aureus typical colony of each plate was transferred to blood agar and 99 
incubated over night at 37°C. DNA isolation kits were supplied by QIAGEN (Hilden, Germany) 100 
and handled according to the manufacturer’s instructions. The concentration of nucleic acids was 101 
measured using Nanodrop ND-1000 UV/Vis spectrophotometer (NanoDrop Technologies, 102 
Wilmington, DE). 103 
 104 
Staphaureux Latex Agglutination Test 105 
 Staphaurex test kit (Oxoid, Basel, Switzerland) was used according to the manufacturer’s 106 
instructions to determine latex agglutination. 107 
 108 
Genotyping using DNA Microarray 109 
 Presence of 284 genes and allelic variants was assessed using StaphyType ArrayStrips 110 
(Clondiag chip technologies, Jena, Germany) following the manufacturer’s instructions. 111 
Multiplex linear DNA amplification and microarray hybridization allowed for identification of 112 
species markers, genes conferring resistance to antimicrobial agents, and virulence determinants 113 
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such as genes encoding enterotoxins, toxic shock syndrome toxin, leukocidins, hemolysins, and 114 
MSCRAMMs. The microarray also enables assignment of strains to clonal complexes and agr 115 
types. DNA microarray profiles were converted to sequence-like strings as described elsewhere 116 
to allow for visualization by SplitsTree4, a software package designed to compute unrooted 117 
phylogenetic networks from molecular sequence data (Huson et al., 2006; Wattinger et al., 2012). 118 
 119 
Susceptibility Testing 120 
 Disk diffusion was used to classify isolates as susceptible, intermediate or resistant 121 
depending on respective zone diameters following CLSI standard protocols (Clinical and 122 
Laboratory Standards Institute, 2008). All antimicrobial agents were chosen with regard to their 123 
relevance in mastitis therapy. Antibiotic agents tested included ampicillin (30 µg), amoxicillin 124 
(20 µg) with clavulanic acid (10 µg), cephalothin (30 µg), ceftiofur (30 µg), erythromycin (15 125 
µg), cefoxitin (30 µg), gentamicin 10 (µg), kanamycin (30 µg), kanamycin-cefalexin (30 µg/ 15 126 
µg), penicillin (10 U.I.), and penicillin-novobiocin (10 U.I/ 30 µg). Mueller-Hinton agar, as well 127 
as disks containing ceftiofur and penicillin-novobiocin were provided by Oxoid, while disks 128 
containing cefalexin-kanamycin (Ubrolexin®) were provided by Boehringer Ingelheim (Basel, 129 
Switzerland). All other disks containing antibiotic agents were obtained from Becton Dickinson 130 
(Basel, Switzerland). Reference strain ATCC 25923 was used as a quality control.  131 
 132 
Statistical Analysis 133 
 The distribution of specific genes among latex-positive and latex-negative isolates was 134 
compared based on the hybridization results of the DNA microarray. SPSS Statistics 19 (SPSS 135 
Inc., Chicago, IL) was used to run Pearson’s chi-squared test, identifying significant associations 136 
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between the latex-phenotype and the presence of the examined genes. Results were considered to 137 
be statistically significant for p-values < 0.050.  138 
 139 
RESULTS  140 
Species Confirmation and Exclusion Criteria 141 
All isolates were confirmed to represent S. aureus using the species markers of the DNA 142 
microarray. To avoid bias, the sample collection was screened for identical isolates by 143 
comparison of all features tested including microarray profiles and resistance patterns, and all 144 
isolates were found to be unique. 145 
 146 
Latex Agglutination and Clonal Complexes 147 
 Latex agglutination was tested for a all 78 confirmed bovine S. aureus strains. While 38 148 
isolates (49%) were latex-positive and would have been correctly identified as S. aureus, 40 149 
isolates (51%) were latex-negative (false-negative). As depicted in the Splitstree in Figure 1, all 150 
latex-negative strains exhibit very similar resistance and virulence gene profiles. They form a 151 
single cluster of isolates assigned to CC151, while latex-positive strains were assigned to various 152 
clonal complexes including CC97 (n = 16), CC8 (n = 10), CC479 (n = 5), CC20 (n = 4), CC7 (n 153 
= 1), and CC45 (n = 1).  154 
 155 
Resistance Phenotypes (Disk Diffusion) 156 
 Resistance phenotypes determined by disk diffusion are listed in Table 1. The SLAT(-) 157 
isolates were susceptible to all antimicrobial agents tested. Among the SLAT(+) group, 24% of 158 
the isolates were classified intermediate with regard to cefalexin-kanamycin and 13 % of isolates 159 
were classified resistant to both ampicillin and penicillin.  160 
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 161 
Resistance and Virulence Gene profiles 162 
Selected DNA microarray results on resistance, and virulence genes are depicted in Table 163 
2. While among SLAT(-) isolates, no resistance genes were detected, some SLAT(+) isolates 164 
exhibited genes involved in resistance to antibiotic agents including blaI/R/Z (26%), ermC (3%), 165 
fosB (39%), and vanB (3%). Several SLAT(+) strains also displayed enterotoxin genes entA 166 
(21%), entD (26%), and entJ (16%), as well as sak encoding staphylokinase (26%), virulence 167 
factors that were not found among latex-negative isolates. In contrast, the SLAT(-) group 168 
exhibited significantly higher prevalence rates of both tested allelic variants of entC, as well as 169 
the egc enterotoxin gene cluster, genes encoding toxic shock syndrome toxin, and leukocidins 170 
lukM/lukF-P83 and lukD. Neither pvl, encoding panton-valentine leukocidin, nor etA/B/C, 171 
encoding exfoliative toxins, were detected in this study. Microarray data on the presence of 172 
selected adhesin genes coding for target proteins of the Staphaureux test is presented in Table 3. 173 
While almost all strains were positive for one or more allelic variants of the adhesin genes tested, 174 
latex-positive and latex-negative isolates differ largely in the allelic variants found. A 175 
comprehensive overview of the prevalence rates of all genes tested is provided as supplemental 176 
file that also comprises p-values used to determine significant differences in the prevalence of 177 
respective genes among SLAT(+) and SLAT(-) isolates.  178 
 179 
DISCUSSION 180 
While Staphaureux test kit exhibits high specificity (99.5%) and sensitivity (99.8%) when applied 181 
to S. aureus strains obtained from humans, it frequently leads to false-negative results when 182 
applied to S. aureus isolates obtained from bovine mastitis milk. We detected 51% SLAT(-) 183 
isolates, consistent with the rate of 54% reported by Stutz et al. (Stutz et al., 2011). In both 184 
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studies SLAT(+) isolates were associated with a wide range of clonal complexes, whereas the 185 
SLAT(-) isolates were assigned to CC151 only. CC151 was reported to represent the most 186 
prevalent clonal complex among S. aureus isolated from bovine milk obtained from both 187 
seemingly healthy, as well as clinically infected udders (Sakwinska et al., 2011; Schlotter et al., 188 
2012; Stutz et al., 2011). The most frequent clonal complexes among SLAT(+) strains in our 189 
study included CC97, CC8, CC497, and CC20, while CC7, CC9, and CC45 were assigned to 190 
only one isolate each. Interestingly, no isolates were assigned to CC133, a dominant clonal 191 
complex among S. aureus isolated from the milk of seemingly healthy cows in Germany 192 
(Schlotter et al., 2012). 193 
When we tested for antimicrobial susceptibility, the resistance proportions among clonal 194 
complexes differed, with CC151, CC479, and CC20 representing the only clonal complexes that 195 
comprised no resistant isolates. These findings are consistent with an extensive study on 196 
antimicrobial resistance among Swiss and French bovine S. aureus isolates, in which penicillin 197 
resistance rates among CC151 and CC20 were found to be far lower than those among CC97 198 
(Sakwinska et al., 2011). Overall, a total of 6% of bovine S. aureus isolates tested in our study 199 
were resistant to both ampicillin and penicillin, and 12% exhibited intermediate susceptibility to 200 
kanamycin/cefalexin. 201 
DNA microarray results indicate that the resistance and virulence gene profiles of the SLAT(-) 202 
strains in our study are highly similar, but differ largely from those of SLAT(+) strains (see 203 
Splitstree, Figure 1). Epidemiological studies suggest that a subset of S. aureus strains exhibits a 204 
distinctive genetic background that renders them highly successful in causing bovine mastitis 205 
(Herron-Olson et al., 2007). The SLAT(-) isolates characterized in our study lack several 206 
virulence genes frequently found among SLAT(+) isolates, including genes coding for resistance 207 
factors, staphylokinase, and enterotoxins A, D, and J. This particular combination of enterotoxin 208 
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genes entA, entD, and entJ was recently described to represent one of the main criteria in the 209 
identification of S. aureus strains classified as genotype B (Boss et al., 2011). Strains of this 210 
genotype were reported to be exclusively associated with very high (up to 65%) within-herd 211 
prevalence of mastitis (Graber et al., 2009). In our study, strains exhibiting the combination of 212 
entA, entC, and entJ were assigned to CC8 only.  213 
Among SLAT(-) strains, we found significantly higher numbers of several other virulence genes, 214 
including genes coding for toxic shock syndrome toxins (tst-1, tst-RF122), enterotoxins (entC, 215 
egc-cluster), and leukocidins (lukM/lukF-P83, lukD). Recent studies suggest lukM/lukF-P83 to 216 
play a role in the pathogenesis of bovine mastitis (Barrio et al., 2006; Schlotter et al., 2012).  217 
As false-negative results in the Staphaurex test are due to impaired functionality of one or several 218 
of the targeted virulence factors Spa, ClfA/B, and FnbA/B, SLAT(-) strains have been 219 
hypothesized to be less virulent than SLAT(+) strains (Stutz et al., 2011). The DNA microarray 220 
results revealed considerable heterogeneity regarding clfA/B and FnbA/B, and we found SLAT(-) 221 
and SLAT(+) isolates to exhibit different alleles of the respective genes. ClfA/B and FnbA/B are 222 
representatives of the group of bacterial surface proteins designated MSCRAMMSs (microbial 223 
surface components recognizing adhesive matrix molecules). These proteins are of particular 224 
interest in the development of vaccines, as they mediate adherence of S. aureus to components of 225 
the host’s extracellular matrix.  226 
 227 
CONCLUSIONS 228 
The genomic background of SLAT(-) and SLAT(+) strains differs significantly, including a vast 229 
range of genes encoding crucial virulence and resistance factors. In consideration of the high 230 
heterogenity among MSCRAMM genes detected by DNA microarray, we conclude that a 231 
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combination of diverse antigens is crucial to the development of highly functional adhesin-based 232 
diagnostic tools and vaccines.  233 
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TABLES 283 
 284 
Table 1: Antimicrobial resistance phenotypes determined by disk diffusion among Staphaurex 285 
latex agglutination test positive (SLAT(+)) and Staphaurex latex agglutination test negative 286 
(SLAT(-)) isolates 287 
1) Abbreviations: AM = ampicillin, AMC = amoxicillin with clavulanic acid, CF = cephalothin, 288 
EFT = ceftiofur, ERY = erythromycin, FOX = cefoxitin, GM = gentamicin, K = kanamycin, 289 
K/CFX = kanamycin-cefalexin, P = penicillin, P/NB = penicillin-novobiocin 290 
 Antimicrobial agents1 
 AM AMC CF EFT ERY FOX GM K K/CFX P P/NB 
SLAT(-)            
CC151 (n = 40) 0 0 0 0 0 0 0 0 0 0 0 
            
SLAT(+)            
CC7 (n = 1) 1 0 0 0 0 0 0 0 0 1 0 
CC8 (n = 10) 1 0 0 0 0 0 0 0 (1)2 1 0 
CC9 (n = 1) 1 0 0 0 0 0 0 0 (1)2 1 0 
CC20 (n = 4) 0 0 0 0 0 0 0 0 (3)2 0 0 
CC45 (n = 1) 1 0 0 0 0 0 0 0 0 1 0 
CC97 (n = 16) 1 0 0 0 0 0 0 0 (4)2 1 0 
CC479 (n= 5) 0 0 0 0 0 0 0 0 0 0 0 
            
total (n = 78) 5  0 0 0 0 0 0 0 (9)2 5 0 
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2) The number of isolates that exhibited intermediate sensitivity to the respective antimicrobial 291 
agent is presented in brackets. 292 
 293 
Table 2: Prevalence of selected virulence and resistance genes detected by DNA microarray 294 
among Staphaurex latex agglutination test (SLAT(+)) and Staphaurex latex agglutination test 295 
negative (SLAT(-)) bovine mastitis isolates 296 
Group Gene/Probe Function SLAT(+) 
(n = 38) 
SLAT(-) 
(n = 40) 
agr typing agrI accessory gene regulator, type I 84% 0%* 
 agrII accessory gene regulator, type II 16% 100%* 
Capsule capsule-5 capsule type 5 79% 0%* 
 capsule-8 capsule type 8 21% 100%* 
Resistance  blaI, blaR, blaZ beta lactamase resistance 26% 0%* 
 fosB putative marker for fosfomycin, 
bleomycin 
39% 0%* 
Enterotoxins entA enterotoxin A 21% 0%* 
 entC enterotoxin C 3% 28%* 
 entCM14 enterotoxin-like protein  3% 100%* 
 entD enterotoxin D 26% 0%* 
 entJ enterotoxin J 16% 0%* 
 egc-cluster enterotoxin gene cluster  29% 100%* 
Toxic shock tst-1 toxic shock syndrome toxin  0% 13%* 
 tst-RF122 allelic variant of toxic shock 
syndrome toxin from RF122 
0% 15%* 
Moser et al., 2012 
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Leukocidins lukM/lukF-P83 bovine leukocidin 42% 100%* 
 lukD leukocidin D component 87% 100%* 
Staphylokinase sak staphylokinase 26% 0%* 
*The prevalence of the respective gene differs significantly between bovine SLAT(+) and 297 
SLAT(-) S. aureus isolates tested in this study (p <0.050). 298 
 299 
Table 3: DNA microarray data on the prevalence of allelic variants of spa, clfA/B, fnbA/B, coding 300 
for proteins targeted by the Staphaurex test. 301 
Target Gene/Probe Function SLAT(+) 
(n = 38) 
SLAT(-) 
(n = 40) 
Spa spa staphylococcal protein A 100% 100% 
ClfA/B clfA-all clumping factor A (ClfA) 97.4% 100% 
 clfA-COL+RF122 ClfA, allele from COL/ RF122 71% 100%* 
 clfB-COL+Mu50 ClfB, allele from COL/ Mu50 26% 0%* 
 clfB-MW2 ClfB, allele from MW2 5% 100%* 
 clfB-RF122 ClfB, allele from RF122 18% 100%* 
FnbA/B fnbA fibronectin-binding protein A (FnbA) 89% 100%* 
 fnbA-COL FnbA, allele from COL 29% 0%* 
 fnbA-MRSA252 FnbA, allele from MRSA252 16% 0%* 
 fnbA-RF122 FnbA, allele from RF122 0% 100%* 
 fnbB-COL+Mu50+MW2 fibronectin-binding protein B (FnbB) 100% 0%* 
*The prevalence of the respective gene differs significantly between the SLAT(+) and SLAT(-) 302 
bovine S. aureus isolates tested in this study (p <0.050). 303 
  304 
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FIGURES 305 
 306 
Figure 1: Splitstree depicting similarity of resistance and virulence gene profiles among SLAT(+) 307 
and SLAT(-) bovine mastitis isolates. CC151 represents the only cluster comprised of SLAT(-) 308 
isolates. The latex phenotype of all isolates clustered in one clonal complex is indicated in 309 
brackets. 310 
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